Ads
related to: cystic fibrosis treatment- Efficacy Data
Studied against the best available
therapies for myelofibrosis
- Mechanism of Action
Learn about the MOA
of a new treatment option
- Efficacy Data
Search results
Adults With Cystic Fibrosis Report Poor Sleep
Medscape· 3 days agoNon-respiratory symptoms including poor sleep, fatigue, pain, anxiety, and depressive symptoms were prevalent among adults with cystic fibrosis (AwCF) and ...
Arcturus reports positive ARCT-032 cystic fibrosis data By Investing.com
Investing.com· 2 days agoHoldings Inc. (NASDAQ: ARCT), a biotechnology company specializing in mRNA medicines, has reported...
What's Going On With Arcturus Therapeutics Stock On Friday? - Arcturus Therapeutics (NASDAQ:ARCT)
Benzinga· 2 days agoArcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoBASEL, Switzerland, June 04, 2024 (GLOBE NEWSWIRE) -- CF AMR Syndicate awarded BioVersys up to £ 500,000 to support project addressing resistant non-tubercular mycobacteria (NTM) lung infections ...
Poppi prebiotic soda brand faces class-action lawsuit over gut health claims
Today· 5 days agoAll is not bright and cheery with colorful prebiotic soda brand Poppi. The lawsuit was filed in the...
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Flipping out with Gymnast Cadie Foynes
WMUR New Hampshire· 3 days agoShe once struggled to breathe, now she's rising to new heights
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Ve
Guru Focus· 6 days agoAccording to the SEC Filing, the transaction was executed at a stock price of $460, totaling $1,495,000. Following this transaction, the insider now owns 47,137 shares of Vertex Pharmaceuticals ...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 6 days agoVRTX stock has rallied nearly 12% so far in 2024. This means it is slightly outperforming the benchmark S&P 500. The stock holds a near-perfect Composite...
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP, Chief Regulatory & Quality ... By...
Investing.com· 5 days ago:VRTX), executed a sale of 4,600 shares of the company. The transaction was conducted at a price of...